ImmunoPrecise Antibodies Ltd. (IPA)

NASDAQ: IPA · IEX Real-Time Price · USD

1.280

-0.080 (-5.88%)

At close: Apr 30, 2024, 4:00 PM

1.320

+0.040 (3.13%)

After-hours: Apr 30, 2024, 6:57 PM EDT

ImmunoPrecise Antibodies Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	34	64	108	165	-	-
Market Cap Growth	-	-40.70%	-34.42%	-	-	-
Enterprise Value	40	63	87	134	1	-2
PE Ratio	-4.26	-3.24	-8.16	-27.65	-	-
PS Ratio	1.91	4.16	7.04	11.33	-	-
PB Ratio	0.93	1.49	1.81	3.57	-	-
P/FCF Ratio	-13.30	-4.03	-12.20	-100.12	-	-
P/OCF Ratio	-15.83	-4.33	-13.74	-338.22	-	-
EV/Sales Ratio	2.24	4.11	5.63	9.19	0.13	-0.24
EV/EBITDA Ratio	-7.18	-4.03	-9.09	-115.96	-4.05	0.65
EV/EBIT Ratio	-4.37	-3.06	-6.88	-30.04	-0.38	0.36
EV/FCF Ratio	-15.07	-3.98	-9.76	-81.18	-0.92	0.68
Debt / Equity Ratio	0.29	0.13	0.04	0.06	0.30	0.16
Debt / EBITDA Ratio	-1.50	-0.35	-0.23	-2.44	-10.04	-0.73
Debt / FCF Ratio	-3.15	-0.34	-0.25	-1.71	-2.29	-0.76
Quick Ratio	0.81	1.52	3.30	7.49	0.80	1.04
Current Ratio	1.66	2.84	4.03	8.05	0.97	1.19
Asset Turnover	0.31	0.26	0.28	0.38	0.51	-
Interest Coverage	-	-	-	-10.60	-8.86	-17.41
Return on Equity (ROE)	-26.70%	-43.00%	-29.10%	-20.90%	-29.80%	-
Return on Assets (ROA)	-18.50%	-32.90%	-24.30%	-15.60%	-17.80%	-
Return on Capital (ROIC)	-25.88%	-43.88%	-21.46%	-11.46%	-20.89%	-29.66%
Earnings Yield	-31.58%	-30.89%	-12.26%	-3.62%	-	-
FCF Yield	-9.84%	-24.81%	-8.20%	-1.00%	-	-
Buyback Yield / Dilution	-3.43%	-26.46%	-19.51%	-20.88%	-8.67%	-
Total Shareholder Return	-3.43%	-26.46%	-19.51%	-20.88%	-8.67%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).